In its latest newsletter, Virnext highlights the role of public-private partnerships in accelerating health innovation and technology transfer.

This issue looks back at key achievements and collaborations throughout 2025, including national and European research programmes, translational and clinical initiatives, and the continued development of international partnerships through RESPIVIR.

It also showcases recent advances in respiratory virology, including innovative vaccine approaches, advanced 3D airway models and new antiviral strategies.

Read the full newsletter:
Virnext Newsletter – 2025